GlassScriptPhysician profile
Baljinder S Bathla
NPI 1154510311
$2,588.52
in general payments reported to CMS, 2019-2025
24 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $563 · 2021: $562 · 2022: $169 · 2023: $254 · 2024: $185 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $417.78 | 2019-2025 | Belbuca, Xtampza |
| Allergan, INC. | $284.18 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $254.60 | 2019-2021 | |
| Medtronic, INC. | $240.94 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $138.70 | 2020-2024 | Senza |
| Avanos Medical | $134.38 | 2022-2025 | Genvisc 850 Sodium Hyaluronate |
| Boston Scientific Corporation | $133.25 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $121.57 | 2021-2023 | Botox |
| Si-Bone, INC. | $108.42 | 2019-2025 | |
| Medtronic USA, INC. | $100.34 | 2019-2020 | |
| Pacira Therapeutics, INC. | $92.81 | 2019-2021 | |
| Pfizer INC. | $91.45 | 2019-2021 | |
| Bioventus LLC | $77.57 | 2019-2025 | Xcell |
| Redhill Biopharma INC. | $56.86 | 2020 | |
| Zyla Life Sciences, INC. | $55.94 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $53.15 | 2019-2021 | |
| Almatica Pharma LLC | $43.26 | 2021 | |
| Stimwave Technologies Incorporated | $40.00 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $38.94 | 2019 | |
| Amgen INC. | $32.55 | 2019 | |
| Depuy Synthes Sales INC. | $19.90 | 2023 | Orthovisc, Monovisc |
| Grt US Holding, INC. | $18.56 | 2021 | |
| Horizon Therapeutics Plc | $16.96 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baljinder Bathla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.